OOIR: Observatory of International Research

Papers

(The H4-Index of Annual Review of Pharmacology and Toxicology is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Nanoparticle Toxicology	195
Arsenic: A Global Environmental Challenge	173
Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span	170
Preventing and Treating Anthracycline Cardiotoxicity: New Insights	96
Targeting NRF2 and Its Downstream Processes: Opportunities and Challenges	90
Model-Informed Precision Dosing: Background, Requirements, Validation, Implementation, and Forward Trajectory of Individualizing Drug Therapy	87
E-Cigarette Toxicology	82
Thioredoxin Reductase Inhibition for Cancer Therapy	79
A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer	68
TRP Channel Cooperation for Nociception: Therapeutic Opportunities	63
Antisense Drugs Make Sense for Neurological Diseases	61
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors	60
Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance	56
Neuropathic Pain: Mechanisms, Sex Differences, and Potential Therapies for a Global Problem	56
Aryl Hydrocarbon Receptor and Its Diverse Ligands and Functions: An Exposome Receptor	48
Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure	47
Endocrine-Disrupting Chemicals and Child Health	46
Brain-Protective Mechanisms of Transcription Factor NRF2: Toward a Common Strategy for Neurodegenerative Diseases	46
Oxidative Stress and Metabolism: A Mechanistic Insight for Glyphosate Toxicology	45
Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer's Disease	42
Artificial Intelligence for Drug Discovery: Are We There Yet?	41
Endocannabinoid-Based Therapies	41
New Drugs, Old Targets: Tweaking the Dopamine System to Treat Psychostimulant Use Disorders	41
CaMKII as a Therapeutic Target in Cardiovascular Disease	40
Oral Biologic Delivery: Advances Toward Oral Subunit, DNA, and mRNA Vaccines and the Potential for Mass Vaccination During Pandemics	39

The CXCL12/CXCR4/ACKR3 Axis in the Tumor Microenvironment: Signaling, Crosstalk, and Therapeutic Targeting	39
Drugs That Regulate Local Cell Signaling: AKAP Targeting as a Therapeutic Option	39
Store-Operated Ca²⁺ Channels: Mechanism, Function, Pharmacology, and Therapeutic Targets	38
G Protein–Coupled Estrogen Receptor GPER: Molecular Pharmacology and Therapeutic Applications	36
Two-Pore Domain Potassium Channels as Drug Targets: Anesthesia and Beyond	36
Drug Target Identification in Tissues by Thermal Proteome Profiling	36
Structural Basis of SARS-CoV-2– and SARS-CoV–Receptor Binding and Small-Molecule Blockers as Potential Therapeutics	36
Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis	35
The Gut Microbiome, Metformin, and Aging	34
Air Pollution–Related Neurotoxicity Across the Life Span	34
Pharmacologic Approach to Sinoatrial Node Dysfunction	34
Mechanism of Action of TiO₂: Recommendations to Reduce Uncertainties Related to Carcinogenic Potential	34